STOCKHOLM, Oct. 18, 2019 /PRNewswire/ -- Moberg
Pharma AB (OMX: MOB) implements changes in the
management team where Mark
Beveridge, VP Finance, reassumes responsibility for the
finance function and replaces Sarah Hellerfelt who has decided to
leave her position as CFO for the company.
Mark Beveridge is a chartered
accountant and joined Moberg Pharma in 2015, previously having
served as senior advisor to the company in accounting and ERP
systems. As Vice President Finance, he is a key member of Moberg's
transaction and finance team. Mark brings extensive experience
within system and financial management with a strong background in
accounting, audit and advisory services.
"I look forward to continue working together
with Mark Beveridge. I
would also like to thank Sarah Hellerfelt for her excellent
contributions to the company over the past years and wish her all
the best in the future", says Anna
Ljung, CEO of Moberg Pharma.
CONTACT:
For additional information, please contact:
Anna Ljung, CEO, telephone:
+46 707 66 60 30, E-mail: anna.ljung@mobergpharma.se
Mark Beveridge, Vice President
Finance, telephone: +46 8 522 307 00, e-mail:
mark.beveridge@mobergpharma.se
About this information
The information was submitted for publication, through the agency
of the contact persons set out above, at 4.00 p.m. CET on October
18th, 2019.
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/moberg-pharma/r/changes-to-moberg-pharma-s-management-team,c2935508
The following files are available for download:
https://mb.cision.com/Main/1662/2935508/1125497.pdf
|
Changes to Moberg
Pharma´s management team
|
View original
content:http://www.prnewswire.com/news-releases/changes-to-moberg-pharmas-management-team-300941245.html
SOURCE Moberg Pharma